Sevoflurane Liquid
Product Images NDC 66794-015

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 66794-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label100ml (Sev 100ml)

Sevoflurane, USP inhalation anesthetic bulk ingredient in liquid form, packaged in a 100 mL container. The label includes the NDC 66794-015-10 and states it is for inhalation anesthesia use only. Manufactured by Piramal Critical Care Inc in Bethlehem, PA, USA. Storage instructions specify 20° to 25°C with allowed excursions from 15° to 30°C.*

FDA Label Image

Figure1 (Sevo Fig1)

A line graph titled 'Fresh Gas Flow Rate versus Compound A Levels in a Circle Absorber System' plotting Compound A levels (ppm) against fresh gas flow rate (L/min). The graph shows a decreasing trend in Compound A levels as fresh gas flow rate increases from 0.5 to 3 L/min, with a slight increase at 4 L/min.*

FDA Label Image

Sevo-fig-10 (Sevo Fig10)

A line graph titled 'Figure 10: Cardiac Index' depicting cardiac index (L/min/m²) on the vertical axis versus MAC level on the horizontal axis. It compares two treatment conditions, Sevoflurane with O2 and Sevoflurane with O2/N2O, showing data points and error bars across baseline and multiple MAC levels up to 2.5.*

FDA Label Image

Figure2 (Sevo Fig2)

A line graph titled 'Carbon Dioxide Flow Versus Compound A and Maximum Temperature' showing the relationship between carbon dioxide flow in mL/min (x-axis) and compound A concentration in ppm along with maximum temperature in degrees Celsius (y-axis). Two data series are shown: compound A ppm (circles) and maximum temperature (squares), both increasing as carbon dioxide flow increases from 0 to 400 mL/min.*

FDA Label Image

Figure2a (Sevo Fig2a)

A scatter plot with a fitted line labeled 'Figure 2a: ppm·hr versus MAC·hr at Flow Rate of 1 L/min.' The x-axis represents sevoflurane exposure (MAC·Hour) ranging from 0 to 9, and the y-axis shows Inspired Compound A AUC (ppm-hr) from 0 to 250. Data points indicate a positive correlation, supported by r = 0.96 and p < 0.001.*

FDA Label Image

Sevo Fig3

Figure 3 is a line graph titled 'Ratio of Concentration of Anesthetic in Alveolar Gas to Inspired Gas' over 40 minutes of administration. The y-axis represents this ratio from 0 to 1, and the x-axis shows minutes of administration from 0 to 40. The graph includes five plotted lines representing anesthetics Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O, each with distinct markers, showing their concentration ratio changes over time.*

FDA Label Image

Sevo Fig4

A line graph depicting the concentration of anesthetic in alveolar gas following termination of anesthesia over time (minutes of elimination). The y-axis shows the ratio of alveolar gas concentration to inspired concentration (FA/FA0) on a logarithmic scale. Five anesthetics are compared: Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O, each represented by different symbols in the legend.*

FDA Label Image

Sevo-fig-5 (Sevo Fig5)

Line chart showing serum inorganic fluoride concentrations (in micromolar) over days post-anesthesia for volatile anesthetics, including Sevoflurane, Methoxyflurane, Enflurane, Isoflurane, and Halothane. The x-axis represents days post-anesthesia from before anesthesia to 6 days after, while the y-axis indicates serum fluoride levels, with data points and error bars illustrating variability.*

FDA Label Image

Sevo-fig-6 (Sevo Fig6)

A line graph depicting fluoride ion concentrations over time following administration of Sevoflurane, with mean concentration and standard deviation intervals shown against time in hours. The y-axis represents concentration in µM and the x-axis represents time up to 50 hours.*

FDA Label Image

Sevo-fig-7 (Sevo Fig7)

A line graph titled 'Figure 7: Heart Rate' showing heart rate measured in beats per minute on the vertical axis and MAC level on the horizontal axis. Two data series are plotted: 'A - Sevo/O2' represented by diamonds and 'C - Sevo/O2/N2O' represented by triangles. The graph includes baseline values and MAC levels 1, 1.5, and 2, with error bars displayed for each data point.*

FDA Label Image

Sevo-fig-8 (Sevo Fig8)

A line graph titled 'Figure 8: Mean Arterial Pressure' showing mean arterial pressure (mmHg) on the vertical axis versus MAC level on the horizontal axis, including baseline data. Two data series are plotted: 'A - Sevo/O2' with diamond markers and 'C - Sevo/O2/N2O' with triangle markers, both showing a decrease in mean arterial pressure as MAC level increases from baseline to 2.0.*

FDA Label Image

Sevo-fig-9 (Sevo Fig9)

Figure 9 is a line graph illustrating systemic vascular resistance in dynes·sec·cm⁻⁵ versus MAC level, with data points for Sevoflurane in oxygen (A - Sevo/O2) and Sevoflurane in a mixture of oxygen and nitrous oxide (C - Sevo/O2/N2O). The graph shows values from baseline to approximately MAC level 2, with error bars indicating variability.*

FDA Label Image

Structure (Sevo Structure)

Chemical structure of sevoflurane, showing its molecular arrangement including fluorine, carbon, oxygen, and hydrogen atoms.*

FDA Label Image

Sevoflurane 250ml

Packaging label for Sevoflurane, USP inhalation anesthetic, liquid dosage form, supplied as 250 mL by Piramal Critical Care Inc. The label includes storage instructions at 20° to 25°C with permissible excursions and a barcode. The product is marked Rx Only and specifies its use for inhalation anesthesia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.